Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Q fever post-vaccination immune response study
NL-OMON35763Recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Jun 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of q fever vaccine in Q fever (4 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoints: Humoral immune response, Cellular immune response and 1 more. Started Jun 2011; status: recruiting.
02
Drugs
q fever vaccine
03
Conditions
Q fever
Beyond the preview
Go deeper on NL-OMON35763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35763.